Design of antimicrobially active small amphiphilic peptide dendrimers

Molecules

Volumn 14, Issue 10, 2009, Pages 3881-3905

  Polcyn, Piotr ^a   Jurczak, Margarita ^a   Rajnisz, Aleksandra ^b   Solecka, Jolanta ^b   Urbanczyk Lipkowska, Zofia ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Antibiotic resistance; Antimicrobial; Dendrimeric peptides

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; DENDRIMER; HEMOLYTIC AGENT;

ARTICLE; CANDIDA; CELL CULTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; SYNTHESIS;

ANTIMICROBIAL CATIONIC PEPTIDES; CANDIDA; CELLS, CULTURED; DENDRIMERS; DRUG DESIGN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYTIC AGENTS; HUMANS;

EID: 70350496755     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14103881     Document Type: Article

References (46)

1. Coates, A.R.M.; Hu, Y. Novel approaches to developing new antibiotics for bacterial infections. British J. Pharm. 2007, 152, 1147-1154.
2. Yacoby, I.; Benhar, I. Antibacterial nanomedicine. Nanomedicine 2008, 3, 329-341.
3. Boas, U.; Heegaard, P.M.H. Dendrimers in drug research. Chem. Soc. Rev. 2004, 33, 43-63.
4. Tomalia, D.A.; Frechet, J.M.J. Introduction to dendrimers and dendritic polymers. Prog. Polym. Sci. 2005, 30, 217-219.
5. Tomalia, D.A.; Frechet, J.M.J. Discovery of dendrimers and dendritic polymers: A brief historical perspective. J. Polym. Sci. A Polym. Chem. 2002, 40, 2719-2728.
6. Stiriba, S.E.; Frey, H.; Haag, R. Dendritic polymers in biomedical applications: From potential to clinical use in diagnostics and therapy. Angew. Chem. Int. Ed. 2002, 41, 1329-1334.
7. Goodman, M.; Cai, W.B.; Kinberger, G.A. The new science of protein mimetics. Macromol. Symposia 2003, 201, 223-236.
8. Gong, E.; Matthews, B.; McCarthy, T.; Chu, J.H.; Holan, G.; Raff, J.; Sacks, S. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antivir. Res. 2005, 68, 139-146.
9. Landers, J.J.; Cao, Z.Y.; Lee, I.; Piehler, L.T.; Myc, P.P.; Myc, A.; Hamouda, T.; Galecki, A.T.; Baker, J.R. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymer. J. Infect. Dis. 2002, 186, 1222-1230.
10. Chaves, F.; Calvo, J.C.; Carvajal, C.; Rivera, Z.; Ramirez, L.; Pinto, M.; Trujillo, M.; Guzman, F.; Patarroyo, M.E. Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkage. J. Pept. Res. 2001, 58, 307-316.
11. Sadler, K.J.; Tam, P. Peptide dendrimers: Applications and synthesis. Rev. Mol. Biotechnol. 2001, 90, 195-229.
12. Svenson, S.; Tomalia, D.A. Dendrimers in biomedical applications- reflections on the field. Adv. Drug Deliv. Rev. 2005, 57, 2106-2129.
13. Dufes, C.; Uchegbu, I.F.A.; Schatzlein, G. Dendrimers in Gene Delivery. Adv. Drug Deliv. Rev. 2005, 57, 2177-2202.
14. Braun, C.S.; Vetro, J.A.; Tomalia, D.A.; Koe, G.S.; Koe, J.G.; Middaugh, C.R. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci. 2005, 94, 423-436.
15. Calabretta, M.K.; Kumar, A.; McDermott, A.M.; Cai, C.Z. Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules 2007, 8, 1807-1811.
16. Czen, C.Z.; Cooper, S.L. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002, 23, 3359-3368.
17. Ortega, P.; Copa-Patiño, J.L.; Muñoz-Fernandez, M.A.; Soliveri, J.; Gomez, R.; de la Mata, F.J. Amine and ammonium functionalized chloromethylsilane-ended dendrimers. Antimicrobial activity studies. Org. Biomol. Chem. 2008, 6, 3264-3269.
18. Cheng, Y.Y.; Qu, H.; Ma, M.L.; Xu, Z.H.; Xu, P.; Fang, Y.J.; Xu T.W. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study. Eur. J. Med. Chem. 2007, 42, 1032-1038.
19. Yung, H.; Lopina, S.T. Penicillin V-Conjugated PEG-PAMAM star polymers. J. Biomat. Sci.- Polym. 2003, 14, 1043-1056.
20. Balogh, L.; Swanson, D.R.; Tomalia, D.A.; Hagnauer, G.L;. McManus, A.T. Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano Lett. 2001, 1, 18-21.
21. Hancock, R.E.W.; Patrzykat, A. Clinical development of cationic antimicrobial peptides: From natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2002, 2, 79-83.
22. Marr, A.K.; Gooderham, W.J.; Hancock, R.E.W. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr. Opin. Pharm. 2006, 6, 468-472.
23. Tam, J.P.; Lu, Y.A.; Yang, J.L. Antimicrobial dendrimeric peptides. Eur. J. Biochem. 2002, 269, 923-932.
24. Rojo, J.; Delgado, R. Dendrimers and dendritic polymers as anti-infective agents: New antimicrobial strategies for therapeutic drugs. Antiinf. Agents Med. Chem. 2007, 6, 151-174.
25. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449, 819-826.
26. Janiszewska, J.; Swieton, J.; Misicka, A.; Lipkowski, A.W.; Urbanczyk-Lipkowska, Z. Small peptide dendrimers with antimicrobial properties. Peptides 2002, 568-567.
27. Janiszewska, J.; Urbanczyk-Lipkowska, Z. Amphiphilic dendrimeric peptides as model nonsequential pharmacophores with antimicrobial properties. J. Mol. Microbiol. Biotechn. 2007, 13, 220-225.
28. Janiszewska, J.; Swieton, J.; Lipkowski, A.W.; Urbanczyk-Lipkowska, Z. Low molecular mass peptide dendrimers that express antimicrobial properties. Bioorg. Med. Chem. Lett. 2003, 13, 3711-3713.
29. Klajnert, B.; Janiszewska, J.; Urbanczyk-Lipkowska, Z.; Bryszewska, M.; Shcharbin, D.; Labieniec, M. Biological properties of low molecular mass peptide dendrimers. Int. J. Pharm. 2006, 309, 208-217.
30. Klajnert, B.; Janiszewska, J.; Urbanczyk-Lipkowska, Z.; Bryszewska, A.; Epand, R.M. DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. Int. J. Pharm. 2006, 327, 145-152.
31. Buhleyer, E.; Wehner, W.; Voegtle, F. Cascade "and non-skid-chain-like" syntheses of molecular cavity topologies. Synthesis 1978, 155-158.
32. McKinney, L.L.; Uhing, E.H.; Setzkorn, E.A.; Cowan, J.C. Cyanoethylation of α-amino acids. I. Monocyanoethyl derivatives. J. Am. Chem. Soc. 1950, 72, 2599-2603.
33. McKinney, L.L.; Uhing, E.H.; Setzkorn, E.A.; Cowan, J.C. Cyanoethylation of alpha amino acids, II. Dicyanoethyl and tricyanoethyl derivatives. J. Am. Chem. Soc. 1951, 73, 1641-1652.
34. Riehm, J.P.; Scheraga, H.A. Structural studies of ribonuclease. XX. Acrylonitrile. A reagent for blocking the amino groups of lysine residues in ribonuclease. Biochemistry 1966, 5, 93-99.
35. Rylander, P.N. Hydrogenation Methods; Academic Press: London, UK, 1985.
36. de Brabander-van den Berg, E.M.M.; Meijer, E.W. Poly(propylene imine) Dendrimers: Large-Scale Synthesis via Heterogeneously Catalyzed Hydrogenation. Angew. Chem. Int. Ed. Engl. 1993, 9, 1308-1311.
37. Brown, H.C.; Choi, Y.M.; Narasimhan, S. Selective reductions. 29. A simple technique to achieve an enhanced rate of reduction of representative organic compounds by borane-dimethyl sulfide. J.O.C. 1982, 47, 3153-3163.
38. Hancock, R.W.E. Cationic peptides: Effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1, 156-164.
39. Dawson, R.M.; Liu, C.Q. Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Critical Rev. Microbiol. 2008, 34, 89-107.
40. Conlon, J.M.; Al-Ghaferi, N.; Abraham, B.; Leprince, J. Strategies for development of naturally occurring antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 2007, 42, 349-357.
41. Fisher, D.; Li, Y. Ahlenmeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24, 1121-1131.
42. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorentz, K.; Frey. H.; Weener, J.W.; Meijer, E.W.; Paulus, W.; Duncan, R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled PAMAM dendrimers in vivo. J. Control. Release 2000, 65, 133-148.
43. Kuroda, K.; Caputo, G.A.; DeGrado, W.F. The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives. Chem. Eur. J. 2009, 15, 1123-1133.
44. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, 2nd ed.; M27-A2; CLSI: Wayne, PA, USA, 2002.
45. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; M07-A7, M100-S17; CLSI: Wayne, Pa, USA, 2006.
46. Rao, S.L.N. Chemical synthesis of N-β-oxalyl-l-α,β- diaminopropionic acid and optical specificity in its neurotoxic action. Biochemistry 1975, 14, 23-31.